# FDA recall D-0757-2023

> **Amerisource Health Services LLC** · Class II · drug recall initiated 2023-03-17.

## Product

Glimepiride Tablets, USP, 1 mg, RX, Packaged as a)100-count bottle, NDC# 68001-177-00; b) 500-count bottle, NDC# 68001-177-03; Manufactured by: Intas Pharmaceuticals Limited, Pharmez, Ahmedabad-382 213. INDIA.  For BluePoint Laboratories

## Reason for recall

CGMP Deviations: recalling drug products following an FDA inspection.

## Distribution

Nationwide USA

## Key facts

- **Recall number:** D-0757-2023
- **Recalling firm:** Amerisource Health Services LLC
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-03-17
- **Report date:** 2023-05-31
- **Termination date:** 2024-09-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Columbus, OH, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0757-2023

## Citation

> AI Analytics. FDA recall D-0757-2023. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0757-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*